Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Masellis

Showing results (241-250 of 368) with videos related to

Pageof 37
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersMaurice Pasternak, Saira S Mirza, Andrew D Paterson, et al.
Nature Communications|October 17, 2018
Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage InferenceAlexandra L Young, Razvan V Marinescu, Neil P Oxtoby, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 10, 2020
Early symptoms in symptomatic and preclinical genetic frontotemporal lobar degenerationTamara Paulo Tavares, Derek G V Mitchell, Kristy Kl Coleman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 1, 2019
New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measuresAdam L Boxer, Michael Gold, Howard Feldman, et al.
Neurology|May 13, 2018
Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2Erik Boot, Nancy J Butcher, Sean Udow, et al.
Brain : a Journal of Neurology|March 28, 2023
Seed amplification and neurodegeneration marker trajectories in individuals at risk of prion diseaseTze How Mok, Akin Nihat, Nour Majbour, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 9, 2022
Evaluation of dose-dependent treatment effects after mid-trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer's diseaseGuoqiao Wang, Yan Li, Chengjie Xiong, et al.
Neurology. Genetics|July 24, 2025
Executive Function Deficits in Genetic Frontotemporal Dementia: Results From the GENFI StudyLucy Louise Russell, Arabella Bouzigues, Rhian S Convery, et al.
Neurology|April 4, 2020
Research criteria for the diagnosis of prodromal dementia with Lewy bodiesIan G McKeith, Tanis J Ferman, Alan J Thomas, et al.
Brain : a Journal of Neurology|February 21, 2022
Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementiaGolia Shafiei, Vincent Bazinet, Mahsa Dadar, et al.
Pageof 37

Showing results (241-250 of 368) with videos related to

Sort By:
Pageof 37
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersMaurice Pasternak, Saira S Mirza, Andrew D Paterson, et al.
Nature Communications|October 17, 2018
Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage InferenceAlexandra L Young, Razvan V Marinescu, Neil P Oxtoby, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 10, 2020
Early symptoms in symptomatic and preclinical genetic frontotemporal lobar degenerationTamara Paulo Tavares, Derek G V Mitchell, Kristy Kl Coleman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 1, 2019
New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measuresAdam L Boxer, Michael Gold, Howard Feldman, et al.
Neurology|May 13, 2018
Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2Erik Boot, Nancy J Butcher, Sean Udow, et al.
Brain : a Journal of Neurology|March 28, 2023
Seed amplification and neurodegeneration marker trajectories in individuals at risk of prion diseaseTze How Mok, Akin Nihat, Nour Majbour, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 9, 2022
Evaluation of dose-dependent treatment effects after mid-trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer's diseaseGuoqiao Wang, Yan Li, Chengjie Xiong, et al.
Neurology. Genetics|July 24, 2025
Executive Function Deficits in Genetic Frontotemporal Dementia: Results From the GENFI StudyLucy Louise Russell, Arabella Bouzigues, Rhian S Convery, et al.
Neurology|April 4, 2020
Research criteria for the diagnosis of prodromal dementia with Lewy bodiesIan G McKeith, Tanis J Ferman, Alan J Thomas, et al.
Brain : a Journal of Neurology|February 21, 2022
Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementiaGolia Shafiei, Vincent Bazinet, Mahsa Dadar, et al.
Pageof 37